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The generation of the human iPSC line, L749.1, was carried out using
retroviruses harboring the reprogramming factors, OCT4, SOX2, CMYC,
KLF4 (Takahashi et al., 2007). For this purpose, ﬁbroblasts from a de-
scribed patient presenting with Leigh syndrome and hypertrophic car-
diomyopathy were obtained. The patient's ﬁbroblasts carried a
heteroplasmic mutation (90%) in the MT-ATP6 gene (c.8993TNG; p.
Leu156Arg) (Pastores et al., 1994). The presence of this mutation in
the iPSC line was evaluated and conﬁrmed by Sanger sequencing
(Fig. 1A). L749.1 iPSC colonies displayed a typical ES-like colony mor-
phology and growth behavior (Fig. 1B) and they stained positive for al-
kaline phosphatase activity (Fig. 1C). We conﬁrmed silencing of the
retroviral transgenes by quantitative RT-PCR using primers speciﬁc for
either the endogenous or transgenic factors OCT4, SOX2 and KLF4
(Fig. 1D). The pluripotency associated transcription factors NANOG,
CRIPTO and REX1were also evaluated by RT-PCR (Fig. 1D). Immunoﬂu-
orescence analysis revealed expression of transcription factors OCT4,
NANOG, SOX2 and surface markers SSEA3, SSEA4, TRA1-60 and TRA1-81
characteristics of pluripotent ES cells (Fig. 1E). Promoters of the
pluripotency associated genes, OCT4 and NANOG, heavily methylated
in the original ﬁbroblasts were almost demethylated in the L749.1 line
suggesting an epigenetic reprogramming to pluripotency (Fig. 1F). The
iPSC line has been adapted to feeder-free culture conditions and dis-
plays a normal karyotype (46, XY) after more than twenty culture pas-
sages (Fig. 1G). We also conﬁrmed by DNA ﬁngerprinting analysis that
the line L749.1 was derived from the patient's ﬁbroblasts (Fig. 1H). Fi-
nally, the capacity of the generated iPSC line to differentiate into thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Molecular and functional characterization of the L749.1 iPSC line. A. Electropherograms showing the mutation in the patient’s ﬁbroblasts and in the L749.1 line. B. Typical ES-like
colony morphology of the L749.1 iPSC line. C. Positive phosphatase alkaline staining. D. QPCR showing the expression of the pluripotency associated markers NANOG, OCT4, SOX2, KLF4,
CRIPTO and REX1. E. Immunoﬂuorescence analysis showing expression of typical pluripotent ES cell markers such as the transcription factors OCT4, NANOG, SOX2 and the surface
markers SSEA3, SSEA4, TRA1-60 and TRA1-81; scale bars: 300μm. F. Bisulﬁte pyrosequencing of the OCT4 and NANOG promoters. The promoters of the transcription factors, OCT4 and
NANOG were almost demethylated in the generated iPSC line. G. Karyotype analysis. L749.1 has a normal karyotype (46, XY). H. DNA ﬁngerprinting analysis showing that L749.1
comes from the patient’s ﬁbroblasts. I. Embryoid body based in vitro differentiation assays. L749.1 differentiates into all three germ layers, demonstrated by positive AFP endoderm
staining, positive Tuj1 ectoderm staining and positive SMA mesoderm staining.
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in vitro using an embryoid body based assay (Fig. 1I).
3. Materials and methods
3.1. Reprogramming of mutant MT-ATP6 ﬁbroblasts into iPSC using
retroviruses
All the experimental protocols included in the present study were
approved by the Institutional Ethical Committee of the Autonoma Uni-
versity of Madrid according to Spanish and European Union legislation.
Human ﬁbroblasts from a described patient presenting with Leigh syn-
drome and hypertrophic cardiomyopathy associatedwith amutation in
the MT-ATP6 gene were acquired in Coriell (GM13411). Subsequently,
these ﬁbroblasts were reprogrammed into iPSCs. For this purpose
pMSCV-based retroviral vectors expressing FLAG-tagged OCT4, SOX2,
KLF4 and c-MYC, kindly provided by Dr. Raya, were used (Raya et al.,
2010). The detailed protocol for the generation of iPSCs by retroviral
transduction is described by Raya et al., 2010. After several passages of
the iPSC line, silencing of the retroviral transgenes was conﬁrmed by
quantitative RT-PCR using primers speciﬁc for either the endogenous
or transgenic factors. L749.1 was maintained and expanded both on
feeder layers and on feeder-free layers. In the ﬁrst case, irradiated
human ﬁbroblast feeders with ES medium containing: Knockout
DMEM (Life technologies), Knockout serum replacement 20%, (Life
technologies), MEM non-essential amino acids solution 1× (Life tech-
nologies), GlutaMAX 1× (Life technologies), β-mercaptoethanol
(100 μM), penicillin/streptomycin 1× (Life technologies) and bFGF
(4 ng/ml) (Miltenyi Biotec) were used. Subsequently, L749.1 was
adapted and cultured in feeder-free conditions on matrigel (354277,
Corning)withmTeSR1medium (StemCell) following the recommenda-
tions of the manufacturer. For the propagation of the line, both enzy-
matic (dispase, collagenase IV and accumax) and mechanical
procedures have been used.
3.2. Phosphatase alkaline analysis
The iPSC line L749.1 was seeded on a feeder layer plate. After seven
days direct phosphatase alkaline activity was determined using the
phosphatase alkaline blue membrane substrate solution kit (Sigma,
AB0300) following the instructions of the manufacturer.
3.3. Mutation analysis
Total DNA from the patient's ﬁbroblasts and iPSCs was extracted
using a standard phenol-chloroform protocol. Subsequently, ampliﬁca-
tion by PCR of theMT-ATP6 gene region containing them.8993TNGmu-
tation was carried out using the following primers: (MITO-13F: 5′-TTTC
CCCCTCTATTGATCCC-3′ and MITO-13R: 5′-GTGGCCTTGGTATGTGCTTT-
3′). Following PCR ampliﬁcation, direct sequencing of amplicons was
performed on both strands in an ABI 3730 sequencer (Applied
Biosystems; Foster City, CA) using a dye terminator cycle sequencing
kit (Applera, Rockville, MD).
3.4. qPCR analyses
Total mRNAwas isolated using TRIZOL and 1 μg was used to synthe-
size cDNA using theQuantitect reverse transcription cDNA synthesis kit.
One microliter of the reaction was used to quantify by qPCR the expres-
sion levels of transgenic and endogenous factors (OCT4, SOX2 and KLF4)
and the pluripotency markers (NANOG, CRIPTO and REX1). Primers se-
quences were described by Aasen et al., 2008. All the expression values
were normalized to the GAPDH housekeeping gene. Plots are represen-
tative of at least three independent experiments.3.5. Bisulﬁte pyrosequencing
Bisulﬁte modiﬁcation of genomic DNA was performed with the EZ
DNAMethylation-Gold kit (Zymo Research) following the manufactur-
er's instructions. The set of primers for PCR ampliﬁcation and sequenc-
ing of NANOG and OCT4 were designed using the software PyroMark
Assay Design (version 2.0.01.15; Qiagen): Forward-NANOG (5′-TAT
TGG GAT TAT AGG GGT GGG TTA-3′), Reverse-NANOG (5′-[Btn]-CCC
AAC AAC AAA TAC TTC TAA ATT CAC-3′), and sequencing primer S-
NANOG (5′-ATA GGG GTG GGT TAT-3′); Forward-OCT4_prox (5′- GGG
GTT AGA GGT TAA GGT TAG TG-3′), Reverse-OCT4_prox (5′-[Btn]-ACC
CCC CTA ACC CAT CAC-3′), and sequencing primer S-OCT4_prox (5′-
GGG GTT GAG TAG TTT-3′); Forward-OCT4_dist (5′-TTT TTG TGG GGG
ATT TGT ATT GA-3′), Reverse-OCT4_dist (5′-[Btn]-AAA CTA CTC AAC
CCC TCT CT-3′), and sequencing primer S-OCT4_dist (5′-ATT TGT ATT
GAG GTT TTG GA-3′). PCR was performed with primers biotinylated to
convert the PCR product to single-stranded DNA templates, using the
Vacuum Prep Tool. After PCR ampliﬁcation, pyrosequencing reactions
and methylation quantiﬁcation were performed using PyroMark Q24
reagents, equipment and software (version 2.0.6; Qiagen), according
to the manufacturer's instructions.
3.6. Karyotype analysis
Karyotype analyses of the iPSC line were carried out using cells with
more than twenty culture passages. These cells were processed using
standard cytogenetic techniques. Brieﬂy, cells were treated with
10 μg/ml of Colcemid (Gibco) for 90 min at 37 °C, trypsinized, treated
with 0.075 M hypotonic KCl solution, and ﬁxed with Carnoy's ﬁxative.
Cells were then dropped on a microscope glass slide and dried. Meta-
phase cells were G banded using Wright staining. At least 20 meta-
phases were karyotyped.
3.7. Immunoﬂuorescence analysis
Cells were grown on 0.1% gelatin-coated P35 culture plates (81156,
Ibidi) and ﬁxed with 4% paraformaldehyde. The following antibodies
for the staining were used: TRA-1-60 (Millipore; MAB4360; 1:150);
TRA-1-81 (Millipore; MAB4381; 1:150); SOX2, (Thermo Scientiﬁc;
PA116968; 1:100); NANOG (R&D Systems; AF1997; 1:25); SSEA-4
(Millipore; MAB4304; 1:10); SSEA-3 (Millipore; MAB4303; 1:10);
OCT4 (Santa Cruz Biotechnology; Sc-5279; 1:100); neuron-speciﬁc
class III beta-tubulin (Tuj1) (Sigma, T8660, 1:300), α-fetoprotein
(AFP) (Sigma, WH0000174M1, 1:300), smooth muscle alpha actin
(SMA) (Sigma, A2547, 1:400). Secondary antibodies used were all
from the Alexa Fluor Series from Jackson Immunoresearch (all 1:500).
Images were taken using a Zeiss confocal microscope.
3.8. In vitro differentiation assay
The in vitro pluripotency capacity of the iPSC line was tested by
spontaneous embryoid body differentiation. For this purpose, iPSCs
from a P100 plate with 80% of conﬂuencywere dissociated into a single
cell suspension with accumax (SCR006,Millipore) and resuspended in
12ml ofmTeSR1medium (Stemcell). Embryoid body formationwas in-
duced by seeding 120 μl of the iPSC suspension in eachwell of 96-well v-
bottom low attachment plates and centrifuging the plates at 800 g for
10 min to aggregate the cells. After 2–3 days the embryoid bodies
were transferred to an untreated P60 culture plate for 2–4 days. Subse-
quently, the embryoid bodies were transferred to 0.1% gelatin-coated
P35 culture plates (81156, Ibidi) and cultured in differentiationmedium
(DMEM F12 supplemented with 20% fetal bovine serum, 2 mM gluta-
mine, 0.1 mM β-mercaptoethanol, 1× nonessential amino acids and
1× penicillin–streptomycin, all from Invitrogen) for 2–3 weeks to
allow spontaneous endoderm formation. For mesoderm differentiation,
iPSCs were maintained for 2–3 weeks in differentiation medium
769T. Galera-Monge et al. / Stem Cell Research 16 (2016) 766–769supplemented with 100 μM ascorbic acid (A4403, Sigma-Aldrich). For
ectoderm differentiation, embryoid bodies were transferred to matrigel
coated P35 culture plates and cultured in a special differentiation me-
dium containing (50% DMEM F12, 50% neurobasal medium, 1×
GlutaMAX, 1× penicillin–streptomycin, nonessential amino acids,
0.1 mM 2-mercaptoethanol, 1× N2 supplement and 1× B27 supple-
ment, all from Invitrogen). In all the cases, the medium was changed
every other day.
3.9. DNA ﬁngerprinting analysis
For DNA ﬁngerprinting analysis, highly polymorphic regions con-
taining short tandem repeated sequences of DNA have been evaluated.
For this purpose, the following markers (D13S317, D7S820, VWA,
D8S1179, D21S11, D19S433, D2S1338 and amelogenin for sex determi-
nation) have been ampliﬁed by PCR and analyzed by ABI PRISM 3100
Genetic analyzer and Peak Scanner v3.5 (Applied Biosystems). Primer
sequences and PCR conditions are available upon request.
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